FluMist Vaccine Approved by CDC Without Proof It Works
Story Highlights The CDC recommended against using the live nasal spray FluMist vaccine for the previous two “flu seasons” due to its ineffectiveness against the H1N1 strain. The CDC has done an about-face for the…
CONTINUE READINGGlobal Vaccine Market Expected to Reach $50.52 billion by 2023
The value of the vaccine market will reach $50.42 billion by 2023 from $36.45 billion in 2018, at a Compound Annual…
CDC Accused of Manipulating Shingles Data
The varicella zoster (chickenpox) virus causes a generally mild and short-lived disease when it occurs in young children under age…
Goldman Sachs Exposes the Cure Dilemma
Story Highlights New gene therapies offer unprecedented hope for permanent cures of serious diseases and hold the promise of an…
How NIH Uses U.S. Tax Dollars to Secure Profits for Vaccine Developers and Manufacturers
It is no secret that huge conflicts of interest exist between vaccine promoters and vaccine makers. Pediatrician and vaccine developer…
Big Pharma Pays Universities for Most Medical Research in U.S. Today
In the past, collaboration between scientists in academia and pharmaceutical companies was relatively uncommon. However, lately there has been a…
Global Vaccines Market Worth $48 Billion by 2025
The global vaccines market is projected to reach $48 billion by 2025, according to new estimates detailed in a report…